Human medicines
Tredaptive
The marketing authorization holder has informed its supplied customers that preliminary results from the HPS2-THRIVE study (Heart Protection Study…
Cefuroxim
The marketing authorization holder informed its supplied customers in a letter dated Dec. 20, 2012, that the batch would be replaced due to unusual…
Urokinase 50.000 I.E.
The distributor has informed its supplied customers that the above batch was intended for Germany or was placed on the market in Austria in German…
Iterium
In a letter dated November 29, 2012, the marketing authorization holder informed the physicians concerned that the shelf life of the physician samples…
EVICEL
The distributor informed its supplied customers in a letter dated November 14, 2012, that a deviation in the manufacturing process, which was…
Update: Fluad, Sandovac
Gelofusin
The marketing authorization holder informed its supplied customers in a letter dated October 24, 2012, that there is a possible pyrogen contamination…
GA-67-MM-1
The marketing authorization holder, in consultation with the French authority, informed its supplied customers by letter dated 10/10/2012 that batch…
Typhim-Vi
Sanofi Pasteur MSD GmbH has informed its supplied customers in a letter dated 24.09.2012 that a voluntary recall is being carried out for the…
Truvada
The parallel distributor, HAEMATO PHARM AG; has informed its supplied customers by letter dated 5.9.2012 that the batches placed on the market by him…
